Medicare needs to consider banning harmful knee osteoarthritis treatments, not effective ones
John W Orchard A and Jessica J Orchard A B
+ Author Affiliations
- Author Affiliations
A Sydney School of Public Health, University of Sydney, NSW 2006, Australia. Email: john.orchard@sydney.edu.au
B Corresponding author. Email: jessica.orchard@sydney.edu.au
Australian Health Review 42(6) 718-719 https://doi.org/10.1071/AH17131
Submitted: 26 May 2017 Accepted: 6 June 2017 Published: 20 March 2018
Additional keywords: health funding and financing, health policy, quality and safety.
References
[1] Mundy L. Platelet-rich plasma: a case study for the identification of disinvestment opportunities using horizon scanning. Aust Health Rev 2017; 41 33–7.| Platelet-rich plasma: a case study for the identification of disinvestment opportunities using horizon scanning.Crossref | GoogleScholarGoogle Scholar |
[2] Dai WL, Zhou AG, Zhang H, Zhang J. Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Arthroscopy 2017; 33 659–70.e1.
| Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials.Crossref | GoogleScholarGoogle Scholar |
[3] Lim HC, Adie S, Naylor JM, Harris IA. Randomised trial support for orthopaedic surgical procedures. PLoS One 2014; 9 e96745 Available at: https://www.ncbi.nlm.nih.gov/pubmed/24927114 <verified 21 December 2017>.
[4] Thorlund JB, Juhl CB, Roos EM, Lohmander LS. Arthroscopic surgery for degenerative knee: systematic review and meta-analysis of benefits and harms. BMJ 2015; 350 h2747
| Arthroscopic surgery for degenerative knee: systematic review and meta-analysis of benefits and harms.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC2Mbkt1KqsA%3D%3D&md5=feaa9e69835a6fdc4ec350045b1459d3CAS |
[5] Cerza F, Carni S, Carcangiu A, Di Vavo I, Schiavilla V, Pecora A, De Biasi G, Ciuffreda M. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med 2012; 40 2822–27.
| Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis.Crossref | GoogleScholarGoogle Scholar |
[6] Sondergaard KB, Weeke P, Wissenberg M, Schjerning Olsen AM, Fosbol EL, Lippert FK, Torp-Pedersen C, Gislason GH, Folke F. Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Eur Heart J Cardiovasc Pharmacother 2017; 3 100–7.
[7] Bally M, Dendukuri N, Rich B, Nadeau L, Helin-Salmivaara A, Garbe E, Brophy JM. Risk of acute myocardial infarction with NSAIDs in real world use: Bayesian meta-analysis of individual patient data. BMJ 2017; 357 j1909
| Risk of acute myocardial infarction with NSAIDs in real world use: Bayesian meta-analysis of individual patient data.Crossref | GoogleScholarGoogle Scholar |
[8] McAlindon TE, LaValley MP, Harvey WF, Price LL, Driban JB, Zhang M, Ward RJ. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA 2017; 317 1967–75.
| Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2sXhtlOnsb3K&md5=2f2b2fe453a8fbe2ebc121c3ee764f78CAS |
[9] Humphreys K. Avoiding globalisation of the prescription opioid epidemic. Lancet 2017; 390 437–39.
| Avoiding globalisation of the prescription opioid epidemic.Crossref | GoogleScholarGoogle Scholar |
